Thursday, July 11
10:30-10:50 AM
EDT
Room 213

Virtual Reality in Pharma Research and Development

Brief Paper ID: 55110
  1. Tom Vasko
    i3Logic
  2. Kelly Voight
    Pfizer
  3. Valerie Gamble
    Pfizer Drug Safety Research and Development and i3Logic
  4. aaa
    Tracey Trower
    Pfizer Drug Safety Research and Development
  5. Cathy Reed-Voorheis
    i3Logic
  6. Doug Braunschweig
    i3Logic
  7. Bonnie Beresford
    i3Logic

Abstract: A pharma research company is piloting a training application of virtual reality (VR) technology to determine if this approach generates anticipated cost savings, improves consistency of the experience, and improves public perception of our research practices. The project goal is to determine if virtual reality training can influence the way the pharma industry looks at how training is conducted. To support this evaluation, extensive metrics are being collected to evaluate if the objectives are met. Seven virtual applications are being piloted and include a restricted laboratory tour, histology/necropsy laboratory safety and general tours, and four toxicology laboratory procedures. For this presentation, we will show a partial virtual laboratory safety tour 360 video.

No presider for this session.

Topic

Conference attendees are able to comment on papers, view the full text and slides, and attend live presentations. If you are an attendee, please login to get full access.
x